R & D- medical: biomedical (applied research/exploratory development)
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272201700077C
- Awardee
-
Profectus Biosciences, Inc. UEI DDRUDKNS37N8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,383,523
Award facts
- Opportunity
-
- BAANIAIDNIHAI2016064 Solicitation number
- Advanced Development of Multivalent Vaccine Candidates for Filovirus and Lassa Fever Award Notice · Posted Apr 29, 2016
- Contract value 100% obligated
- $3,383,522.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$4,855,064 | |
| Supplemental Agreement for work within scope | $0 | |
| Close Out | $0 | |
| Supplemental Agreement for work within scope | $1,177,051 | |
| Supplemental Agreement for work within scope | $97,016 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $6,964,520 |
About this award
This is a Cost Plus Fixed Fee contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Profectus Biosciences, Inc., a small business. The contract, with a potential value of $3,383,522.51, is for research and development in the biomedical field, specifically focused on applied research and exploratory development of vaccine technologies. The contract does not have a set-aside designation. Over the years, Profectus Biosciences has maintained a consistent relationship with HHS-NIH, demonstrating expertise in the development of novel vaccine strategies and production of vaccine candidates such as pDNA vaccine expressing FLSC and HIV-1 vaccine candidates.
Quick answers
Who was awarded contract HHSN272201700077C?
HHSN272201700077C was awarded to Profectus Biosciences, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2017.
How much is contract HHSN272201700077C worth?
The government has obligated $3,383,523 on HHSN272201700077C.
Was contract HHSN272201700077C competed?
The extent of competition for HHSN272201700077C was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award